108 related articles for article (PubMed ID: 8496905)
1. Synthesis and analgesic effects of N-[3-[(hydroxyamino) carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymes.
Doulut S; Dubuc I; Rodriguez M; Vecchini F; Fulcrand H; Barelli H; Checler F; Bourdel E; Aumelas A; Lallement JC
J Med Chem; 1993 May; 36(10):1369-79. PubMed ID: 8496905
[TBL] [Abstract][Full Text] [Related]
2. Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus.
Kitabgi P; Dubuc I; Nouel D; Costentin J; Cuber JC; Fulcrand H; Doulut S; Rodriguez M; Martinez J
Neurosci Lett; 1992 Aug; 142(2):200-4. PubMed ID: 1454216
[TBL] [Abstract][Full Text] [Related]
3. New hydroxamate inhibitors of neurotensin-degrading enzymes. Synthesis and enzyme active-site recognition.
Bourdel E; Doulut S; Jarretou G; Labbe-Jullie C; Fehrentz JA; Doumbia O; Kitabgi P; Martinez J
Int J Pept Protein Res; 1996 Aug; 48(2):148-55. PubMed ID: 8872532
[TBL] [Abstract][Full Text] [Related]
4. Calcium-dependent release of neuromedin N and neurotensin from mouse hypothalamus.
Kitabgi P; De Nadai F; Cuber JC; Dubuc I; Nouel D; Costentin J
Neuropeptides; 1990 Feb; 15(2):111-4. PubMed ID: 2080018
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
6. Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n.
Coquerel A; Dubuc I; Kitaegi P; Costentin J
Neurochem Int; 1988; 12(3):361-6. PubMed ID: 20501239
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of neurotensin and neuromedin N by Zn metallopeptidases.
Kitabgi P
Peptides; 2006 Oct; 27(10):2515-22. PubMed ID: 16904239
[TBL] [Abstract][Full Text] [Related]
9. Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa.
Barelli H; Mao YK; Vincent B; Daniel EE; Vincent JP; Checler F
Peptides; 1993; 14(3):457-63. PubMed ID: 8332546
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
[TBL] [Abstract][Full Text] [Related]
11. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
13. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation.
Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
Eur J Pharmacol; 1997 Sep; 334(1):49-53. PubMed ID: 9346327
[TBL] [Abstract][Full Text] [Related]
14. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation.
Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137
[TBL] [Abstract][Full Text] [Related]
15. JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse.
Dubuc I; Costentin J; Doulut S; Rodriguez M; Martinez J; Kitabgi P
Eur J Pharmacol; 1992 Aug; 219(2):327-9. PubMed ID: 1425958
[TBL] [Abstract][Full Text] [Related]
16. Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities.
Chen H; Noble F; Mothé A; Meudal H; Coric P; Danascimento S; Roques BP; George P; Fournié-Zaluski MC
J Med Chem; 2000 Apr; 43(7):1398-408. PubMed ID: 10753476
[TBL] [Abstract][Full Text] [Related]
17. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
[TBL] [Abstract][Full Text] [Related]
18. Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study.
Villeneuve P; Feliciangeli S; Croissandeau G; Seidah NG; Mbikay M; Kitabgi P; Beaudet A
J Neurochem; 2002 Aug; 82(4):783-93. PubMed ID: 12358783
[TBL] [Abstract][Full Text] [Related]
19. PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects.
Kleczkowska P; Kosson P; Ballet S; Van den Eynde I; Tsuda Y; Tourwé D; Lipkowski AW
Mol Pain; 2010 Dec; 6():86. PubMed ID: 21134256
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic.
Hughes FM; Shaner BE; May LA; Zotian L; Brower JO; Woods RJ; Cash M; Morrow D; Massa F; Mazella J; Dix TA
J Med Chem; 2010 Jun; 53(12):4623-32. PubMed ID: 20481538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
